Background: Increased triglycerides (TG) and decreased high-density lipoprotein cholesterol (HDL-C) are risk factors for type 2 diabetes (T2D). The relationship between TG:HDL-C ratio and T2D risk is not clear, and it is not known whether the association is modified by gender, body mass index, or fasting status. This study examined the relationship between TG:HDL-C ratio and risk of incident T2D, and the predictive ability of the ratio on top of other diabetes risk factors. Methods: Blood biomarkers were determined in 571 T2D cases and 571 controls nested within a prospective, population-based cohort study, the Singapore Chinese Health Study. Participants were free of diagnosed diabetes, cardiovascular disease, and cancer at the time of blood collection (1999)(2000)(2001)(2002)(2003)(2004). Incident self-reported T2D cases were identified at follow-up interview (2006-10). Controls were matched 1: 1 for age, sex, dialect group, and date of blood collection. Multivariable logistic regression was used to compute the odds ratio (OR) and 95 % confidence interval (CI). Results: The ORs (95 % CI) of T2D per 1-SD increment in TG and TG: HDL-C ratio were 1.70 (1.39-2.09) and 1.72 (1.37-2.17), respectively. The relationships were stronger among females than males (P interaction = 0.028 and 0.017, respectively), and stronger among lean (<23 kg/m 2 ) than overweight/obese participants (P interaction = 0.051 and 0.046, respectively). Both TG and TG: HDL-C improved T2D prediction to a similar degree. Conclusions: Both TG and TG:HDL-C ratio are independent risk factors for incident T2D, and confer greater risk in women and lean participants. The TG: HDL-C ratio is not a better predictor of diabetes than TG alone.
Introduction
Dyslipidemia, especially increased triglycerides (TG) together with decreased high-density lipoprotein cholesterol (HDL-C) levels, is strongly correlated with insulin resistance and type 2 diabetes (T2D). 1 Mechanistic studies suggest that high TG and low HDL-C levels may be causal factors for T2D, 2 and this inference has been supported by various epidemiological and genetic studies. Prospective human studies found that high TG and low HDL-C levels are independent risk factors for T2D, and TG and/or HDL-C values have been included in models to predict T2D risk. 3, 4 Moreover, a recent Mendelian randomization study showed that genetic predisposition to high TG levels or low HDL-C levels was causally related to elevated T2D risk. 5 Although recent studies demonstrated that the TG: HDL-C ratio could be a better predictor of insulin resistance and cardiovascular disease (CVD) than TG or HDL-C alone, 6, 7 the association between the TG: HDL-C ratio and T2D is not entirely clear as yet. So far, only a few prospective studies have examined this issue, [8] [9] [10] [11] [12] [13] and the extent to which the TG: HDL-C ratio is independently related to T2D risk has been variable. Some studies found a positive association, [8] [9] [10] [11] [12] whereas one study showed a null association. 13 Moreover, few studies have explored whether the association is modified by gender 8, 10 and fasting status. 10 One study reported a slightly stronger association between the TG: HDL-C ratio in women compared with men, 8 although a formal interaction test was not performed. Another study found an association between the TG: HDL-C ratio and T2D risk in both men and women, regardless of fasting status. 10 In addition, previous studies have found ethnic differences in ability of the TG: HDL-C ratio to identify insulin resistance. 6, 14 Because Asians develop T2D at lower body mass index (BMI) compared with Western populations, 15 lipids may play a more important role in T2D development in relatively lean Asian populations. However, to the best of our knowledge, no study has explored whether the association between the TG: HDL-C ratio and T2D risk is modified by BMI. Moreover, it is unknown whether the TG: HDL-C ratio adds substantial predictive information for T2D. One study reported the predictive ability of the TG: HDL-C ratio together with other risk factors for T2D, without presenting discrimination improvement by the TG: HDL-C ratio alone. 8 Another study reported that the TG: HDL-C ratio improved T2D prediction, but the sample size was relatively small (74 T2D cases). 9 To address these issues, we conducted a nested casecontrol study within the Singapore Chinese Health Study (SCHS) to examine the relationship between the TG: HDL-C ratio and risk of incident T2D, as well as possible interactions with gender, obesity, and fasting status. Moreover, we evaluated the predictive ability of the TG: HDL-C ratio, TG alone, and HDL-C alone, on top of other diabetes risk factors.
Methods

Study population
The design of the SCHS has been described previously. 16 Briefly, the SCHS was established between 1993 and 1998 and recruited 63 257 Chinese adults aged 45-74 years. At recruitment, an in-person interview was conducted using a structured questionnaire to collect health-related information. Follow-up I was conducted via telephone between 1999 and 2004 to update selected lifestyle habits and medical history. In all, 52 322 participants were successfully recontacted, and 32 535 consented to provide biospecimens. Follow-up II was conducted between 2006 and 2010, with 39 528 participants were successfully recontacted. Of the 32 535 participants with available biospecimens, 25 477 (78.3 %) were contacted at Follow-up II. The study protocol was approved by the Institutional Review Board at the National University of Singapore.
Ascertainment of diabetes and other covariates
A history of physician-diagnosed diabetes was determined at baseline and both follow-up interviews by the question, "Have you been told by a doctor that you have diabetes?". If the answer was "yes", participants were also asked for the age at which they were first diagnosed. The robustness and accuracy (98.9 %) of the selfreported diabetes data was validated in a separate study analyzing 1651 cohort participants (949 cases by medical records and 702 via telephone interview). 17 Body weight and height were self-reported at baseline and both follow-up interviews. BMI was calculated as weight (in kg) divided by height (in m) squared. Alcohol consumption was coded as never, weekly and daily drinking, and smoking status was coded as never, former, and current smoking based on Follow-up I questionnaires. Weekly moderate-to-vigorous activity levels (<0.5, 0.5-3.9, and ≥4.0 h/week) and education level (none, primary school, secondary school and above) were obtained from the baseline questionnaires.
Selection of cases and controls
A nested case-control study of 571 cases and 571 matched controls within the SCHS was established for the present analysis. All cases and controls were free of physician-diagnosed diabetes, CVD, and cancer at baseline interview as well as at the time of blood collection (1999) (2000) (2001) (2002) (2003) (2004) . Cases were those who reported to be diagnosed with incident diabetes during Follow-up II visits . Controls were selected from the remaining participants who were free of T2D at Follow-up II, and were matched 1: 1 with the cases for age (±3 years), date of blood collection (±6 months), sex, and dialect group. In addition, selected controls were screened for the presence of undiagnosed T2D at the time of blood sample collection by measuring HbA1c levels. All matched controls with HbA1c ≥6.0 % were ineligible for the study and were excluded, with a replacement control with the same matching criteria randomly chosen from the remaining eligible controls.
Laboratory procedures
A 20-mL sample of peripheral blood was obtained from each consenting participant. The tubes were put on ice during transport from the participants' homes to the laboratory immediately after blood collection. All specimens were separated into various components (plasma, serum, red blood cells, and buffy coat). All specimens were subsequently stored in À80°C freezers for longterm storage. Frozen plasma aliquots from cases and controls were assayed simultaneously at the National University Hospital Reference Laboratory, Singapore.
Plasma concentrations of total cholesterol (TC), TG, HDL-C, and high-sensitivity C-reactive protein (hs-CRP) were measured using colorimetric method on a chemistry analyzer (AU5800; Beckman Coulter, Brea, CA, USA). Adiponectin levels were determined by ELISA (Bio-Rad Laboratories, Hercules, CA, USA). Low-density lipoprotein cholesterol (LDL-C) levels were calculated using the Friedewald formula as follows:
LDL-C = TC -HDL-C -TGs/2.2. where TG did not exceed 4.5 mmol/L. Thus, 44 participants had missing values for LDL-C because of high TG levels.
Statistical analysis
Based on the distribution among control participants, lipid measures (HDL-C, LDL-C, TG, and TG: HDL-C) were divided into tertiles, with the lowest tertile serving as the reference group. We used conditional logistic regression to model the association between lipid measures and T2D risk with adjustment for age at blood collection (continuous), smoking status (never, past, and current smoker), alcohol intake (never, weekly, or daily), weekly moderate-to-vigorous activity levels (<0.5, 0.5-3.9, and ≥4.0 h/week), education level (none, primary school, secondary or above), history of hypertension (yes, no), fasting status (yes, no), BMI (continuous), and plasma concentrations of hs-CRP and adiponectin in tertiles. We also calculated the odds ratio (OR) of T2D per standard deviation (SD) increment in lipid measures with the same adjustment mentioned above. We tested potential interactions between lipid measures and gender, obesity, and fasting status. We used unconditional logistic regression models with additional adjustment for matching factors on gender (male, female) and dialect group (Cantonese, Hokkien) when performing stratified analysis on obesity and fasting status.
To assess the predictive utility of each lipid measure, we established a parsimonious logistic regression model including education level, weekly activity, history of hypertension, and BMI using a forward selection procedure (P < 0.05). The improvement in discrimination was examined by comparing the area under the receiveroperating characteristic curve (AUC ROC ) between the parsimonious model and the model plus one lipid measure using the method from DeLong et al. 18 Moreover, due to limitations of AUC ROC , such as its insensitivity to model improvement, 19 we also evaluated the category-free net reclassification improvement (NRI) and integrated discrimination improvement (IDI) statistics. 20 The NRI is calculated from a sum of differences between higher predicted risk for events and lower predicted risk for non-events, 20 whereas the IDI is based on differences in integrated average sensitivities and 'one minus specificities' between models with and without the new biomarker. 20 Furthermore, the goodnessof-fit of all models was assessed by the Akaike information criterion (AIC), where a lower AIC value indicates better model fit. In addition, we tested the predictive utility of these lipid measures in different gender and BMI groups. Analyses were performed using Stata version 11.0 (Stata Corp., College Station, TX, USA).
Results
Among T2D cases, the mean (±SD) age at diagnosis was 63.2 ± 6.4 years and the mean (±SD) duration between blood donation and diagnosis of T2D was 4.0 ± 1.7 years. The baseline characteristics of cases and controls are given in Table 1 . Cases had high-risk profiles except for the matching factors. They had higher BMI and were more likely to have a history of hypertension. No significant differences were found in education levels, cigarette smoking, alcohol consumption, physical activity levels, and fasting status. Cases had higher baseline levels of hs-CRP, TG, and TG: HDL-C, and lower adiponectin and HDL-C levels. There was no significant difference in LDL-C levels between cases and controls.
Among the healthy control participants, the TG: HDL-C ratio was inversely correlated with levels of HDL-C, LDL-C, and plasma adiponectin levels (Pearson's coefficient r = À0.76, À0.17, and À0.49, respectively; all P < 0.001), and positively correlated with TG level, BMI and plasma hs-CRP levels (Pearson's coefficient r = 0.95, 0.19 and 0.14, respectively; all P < 0.01; see Table S1 , available as Supplementary Material to this paper).
The associations between lipid measures and risk of incident T2D are presented in Table 2 . Higher levels of TG and the TG: HDL-C ratio were positively associated with risk of T2D, whereas increased HDL-C levels were inversely associated with T2D risk. However, LDL-C was not significantly associated with T2D risk. In the final model, T2D risk was increased by 70 % per 1-SD increment in TG (OR 1.70; 95 % CI 1.39-2.09) and by 72 % per 1-SD increment in the TG: HDL-C ratio (OR 1.72; 95 % CI 1.37-2.17), but was decreased by 32 % per 1-SD increment in HDL-C (OR 0.68; 95 % CI 0.56-0.82).
We further performed stratified analysis to explore whether the observed associations were modified by gender (Table 3) , BMI (Table 4) , or fasting status (Table S2 ). The associations of TG and the TG: HDL-C ratio with T2D risk were stronger among women than men (P interaction = 0.028 and 0.017, respectively), and stronger among lean participants (<23 kg/m 2 ) than among overweight/obese participants (≥23 kg/m 2 ; P interaction = 0.051 and 0.046, respectively). The associations were consistent across all other subgroups and interaction tests were not statistically significant.
The summary statistics for the predictive performance of lipid measures are presented in Table 5 . Compared with the AUC ROC of the base model, inclusion of HDL-C, TG, or the TG: HDL-C ratio significantly improved AUCs (P < 0.05) to a similar degree. Furthermore, the positive values for NRIs and IDIs also suggested that inclusion of lipid measures significantly improved T2D risk prediction (all P < 0.001). Although TG had slightly higher NRI and IDI statistics than the TG: HDL-C ratio and HDL-C, overall the three lipid measures provided similar improvements in T2D prediction. The NRI table stratified for T2D cases and controls is presented in Table S3 . Specifically, the inclusion of HDL-C resulted in 24.3 % of T2D cases correctly assigned to a higher predicted T2D risk and 6.5 % of controls correctly assigned to a lower predicted T2D risk. When TG and the TG: HDL-C ratio were added to the model separately, 0.9 % and À5.4 % of cases, respectively, were reclassified as higher T2D risk, whereas 40.4 % and 42.9 % of controls, respectively, were reclassified as lower T2D risk. When stratified by gender, the improvement of three lipid measures in T2D prediction was only found in women (Table S4) . However, when stratified by BMI level, the performance of lipid measures was consistent across all subgroups (Table S5) .
Discussion
In the present case-control study nested within the SCHS, we found that TG and the TG: HDL-C ratio were associated with increased risk of incident T2D, whereas HDL-C was related to a lower risk of T2D. Moreover, the positive associations with TG and the TG: HDL-C ratio were significantly stronger among women and lean participants compared with their counterparts. Furthermore, TG, HDL-C, and the TG: HDL-C ratio all significantly improved T2D risk prediction, but the TG: HDL-C ratio was not a better predictor than TG alone. Our finding of a positive association between the TG: HDL-C ratio and T2D risk is supported by previous studies in Chinese, 9 Iranian, 8, 12 Japanese, 10 and Caucasian 11 men, despite the heterogeneity in statistical methods (studies modeled the TG: HDL-C ratio as either a continuous variable, 8, 9 a binary variable with a cut-off point, 11, 12 or in quartiles 10 ). However, one prospective study showed a null association. 13 That study was conducted in a group of Iranian people (without diabetes) with a family history of diabetes and participants had much higher BMI and TG: HDL-C ratios compared with subjects in the present study (mean BMI 29 vs 23 kg/m 2 , respectively; TG: HDL-C ratio 4.0 vs 1.3, respectively); therefore, the TG: HDL-C ratio may not predict T2D risk in this specific high-risk population.
In the present study, we found a similar strength of association for TG and the TG: HDL-C ratio for diabetes risk, which is in accordance with previous studies. 8, 9 Moreover, LDL-C was not associated with T2D risk in the present study, which is in agreement with the findings from the Framingham Heart Study. 21 A possible causal relationship between high TG and low HDL-C levels and T2D risk is supported by several lines of evidence. Lipotoxicity, inflammation, and endoplasmic reticulum (ER) stress are three widely accepted mechanisms causing insulin resistance. [22] [23] [24] Recent data indicate that high TG levels provoke lipotoxicity, cause overload of free fatty acid levels in the skeletal muscle and pancreas, and lead to insulin resistance, β-cell dysfunction, and apoptosis. 25 Meanwhile, high TG levels could directly promote inflammation or ER stress. 1 In addition, low HDL-C levels may affect glucose homeostasis by reducing insulin secretion, insulin sensitivity, and direct glucose uptake by muscle via AMP-activated protein kinase. 22 Results from prospective studies across The linear trend was tested using the median level of each tertile of the blood lipid profile. Model 1 was adjusted for age when blood was taken, smoking status, alcohol intake, weekly activity, education level, history of hypertension, and fasting status. Model 2 was adjusted for all the factors in Model 1 plus body mass index. Model 3 was adjusted for all the factors in Model 2 plus plasma concentrations of C-reactive protein and adiponectin (both in tertiles). HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; OR, odds ratio; CI, confidence interval.
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ethnic groups also reported that high TG and low HDL-C levels were independent risk factors for T2D risk. 3, 4 Moreover, clinical trials conducted in high-risk populations showed that drugs to decrease TG levels and increase HDL-C levels (e.g. bezafibrate) can lower the T2D risk. 26 Furthermore, a recent Mendelian randomization study testing 25 loci (accounting for 10 % of the genetic variation) further supported the causal relationship between high TG and low HDL-C levels with T2D risk, 5 although a previous Mendelian randomization study with fewer loci (10 loci accounting for 3 %-5 % of the genetic variation) implied no causal relationship. 27 Together, these findings suggest that we may be able to prevent T2D by modulating TG and HDL-C levels.
In addition, the present study showed significant gender differences in the relationship of TG and the TG: HDL-C ratio with T2D risk, and the associations were significantly higher in women than in men. The same finding was reported in an Iranian population, although a formal interaction test was not performed. 8 In addition, the observed gender difference in the association is supported by other studies of TG and T2D risk prediction in a Japanese population, 10 and of the TG: HDL-C ratio and insulin resistance in a population of primarily European ancestry. 28 However, further studies are warranted to confirm this finding in other populations. The underlying mechanism for the observed gender difference is unclear and we speculate that it may be due to sex hormones. Declines in estrogen levels after menopause lead to dysregulation of glucose and lipid metabolism, 29 and thus may put women at greater risk of developing T2D. A similar pattern has been observed for the association between TG levels and increased CVD risks, where it is stronger in women than in men, 30 and the National Cholesterol Education Program Multivariate model adjusted for age when blood was taken, smoking, alcohol intake, physical activity, education level, history of hypertension, fasting status), body mass index, and plasma concentrations of C-reactive protein and adiponectin (both in tertiles).
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The linear trend was tested using the median level of each tertile of the blood lipid profile.
3
P interaction between triglycerides (TG) and sex is 0.028.
4
P interaction between the TG: high-density lipoprotein cholesterol (HDL-C) ratio and sex is 0.017. OR, odds ratio; CI, confidence interval; LDL-C, low-density lipoprotein cholesterol.
has suggested more aggressive targets for HDL-C and TG in women to prevent CVD compared with men. 31 Therefore, the findings from the present study, along with previous studies, 8, 10, 28 imply that the gender difference should be considered in T2D prevention as well.
Moreover, the present study found slightly higher relationships between TG and the TG: HDL-C ratio with T2D risk in lean people than in their heavier counterparts. Although the underlying mechanism is as yet unclear, one possible explanation for the observed interaction with obesity may be due to differences in the dominant pathogenesis pathway driving T2D development between lean and obese individuals. In lean people, dyslipidemia may play a more important causal role in T2D development, whereas in obese counterparts other mechanism related to adiposity, such as low-grade inflammation, may play a more prominent role. Alternatively, in obese people, the increased T2D risk by increased TG may be attenuated by other mechanisms. Multivariate model adjusted for age when blood taken, gender, dialect group, smoking status, alcohol intake, physical activity, education level, history of hypertension, fasting status, and plasma concentrations of C-reactive protein and adiponectin (both in tertiles).
The linear trend was tested using the median level of each tertile of blood lipid profile.
3
P interaction between triglycerides (TG) and body mass index (BMI) is 0.051.
4
P interaction between the TG: high-density lipoprotein cholesterol (HDL-C) ratio and BMI is 0.046. OR, odds ratio; CI, confidence interval; LDL-C, low-density lipoprotein cholesterol. For example, adiponectin was associated with a significantly decreased risk of T2D in obese people, but its effect was less apparent in non-obese counterparts in Western and Asian populations. 32, 33 Nevertheless, the sample size for the subgroup analysis in the present study was small and the results should be interpreted cautiously.
The findings also highlight that lean appearance does not necessarily equate to being healthy. Therefore, it is important for clinical practice to identify lean people with high TG levels as a population at high risk of developing T2D, and lean people may receive greater benefit from decreasing T2D risk by altering lipid levels compared with overweight/obese people. However, Asians tend to develop T2D at lower BMI compared with Western populations, 15 which may be due, in part, to their propensity to store fat viscerally rather than subcutaneously. 34 In addition, compared with non-Asian populations, Asians are more insulin resistant, even in relatively lean individuals, and have lower β-cell function to overcome insulin resistance. 35 Because of the biological differences between Asians and non-Asians, whether the observed interaction with BMI in the present study will remain in non-Asian populations is unclear.
The present study found that TG, HDL-C, and the TG: HDL-C ratio improved T2D risk prediction to a similar degree. In line with the present study, Hadaegh et al. 8 also found the same improvements in AUCs by TG, HDL-C (only in women), and the TG: HDL-C ratio. In addition, He et al. 9 found similar AUC improvements between TG and the TG: HDL-C, with values similar to those reported in the present study. Although recent studies suggest that the TG: HDL-C ratio could be better predictor for insulin resistance and CVD than TG or HDL-C alone, 6, 7, 36 a superiority of the TG: HDL-C ratio in disease prediction was not observed for T2D.
The strength of the present study was its prospective design and hence the presumed lack of recall bias in exposure data (questionnaires, collected biospecimens) prior to T2D diagnosis. However, there are some limitations to the present study as well. First, we measured TG and HDL-C only once at baseline and this may not represent the long-term lipid profile. However, this would lead to non-differential misclassification and may underestimate the association. Second, incident diabetes was obtained from self-reported information; although our validation study suggested that individuals who reported to have diabetes were more likely to be true diabetes cases, undiagnosed diabetes may still exist in the population. Third, more than 70 % of blood samples were nonfasting, and this may have affected lipid levels. However, stratified analysis was performed among fasting and non-fasting groups, and similar associations were found between lipid measures and T2D risk in the two groups, indicating non-fasting status did not affect the associations in the present study. Recent European clinical guidelines also concluded that "…fasting is not routinely required for determination of a lipid profile". 37 Moreover, the present study used a matched case-control study design; although this design is valid in studying associations, recent studies have pointed out that it may introduce bias when studying the predictive utility of biomarkers.
38,39
Conclusion
In conclusion, the present study demonstrated a strong, dose-dependent relationship between both TG and the TG: HDL-C ratio and T2D risk, with the association being stronger in women and lean participants compared with their counterparts. In addition, both TG and the TG: HDL-C ratio significantly improved T2D risk prediction, but the TG: HDL-C ratio was not a better predictor than TG alone. The findings suggest that women and lean people may receive greater benefit from decreasing T2D risk by altering lipid levels compared with men and overweight/obese people. Further research is needed to validate the findings and investigate the biochemical and genetic mechanisms for the associations and heterogeneity observed between TG levels and the development of T2D.
